Sepsis Trial Update Sending Shares of this Medical Device Maker Higher
2024年8月2日 - 3:20AM
AllPennyStocks.com
This Phase 3 company is seeking U.S. FDA approval for its unique
product for the treatment of patients with septic shock, and shares
are moving up.
Late-stage theranostic company Spectral...
To read the full story on AllPennyStocks.com, click
here.
Spectral Medical (TSX:EDT)
過去 株価チャート
から 10 2024 まで 11 2024
Spectral Medical (TSX:EDT)
過去 株価チャート
から 11 2023 まで 11 2024
